Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.4239
-0.0081 (-1.87%)
At close: Feb 20, 2026, 4:00 PM EST
0.4209
-0.0030 (-0.71%)
After-hours: Feb 20, 2026, 7:35 PM EST
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $67.46 million as of February 20, 2026. Its market cap has decreased by -86.43% in one year.
Market Cap
67.46M
Enterprise Value
19.15M
1-Year Change
-86.43%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $67.46M, a decrease of -45.96%. That is a compound annual growth rate of -8.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 67.46M | 1.73% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 72.16M |
| Fractyl Health | 71.82M |
| XBiotech | 70.43M |
| TuHURA Biosciences | 69.83M |
| ETHZilla | 68.63M |
| Entera Bio | 67.41M |
| Kazia Therapeutics | 66.85M |
| Annovis Bio | 65.73M |